Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, today announces the successful Phase II enrollment of approximately ten patients of whom the majority have already been transplanted and received ATIRa .
http://www.biospace.com/news_story.aspx?StoryID=316062&full=1
http://www.biospace.com/news_story.aspx?StoryID=316062&full=1
No comments:
Post a Comment